Endometriosis: a pain trial in Aberdeen

A five-year UK trial will test a twelve-week programme for endometriosis pain. What is known, and what remains to be proven.

· News · Health

The news in brief

The University of Aberdeen is preparing a five-year, £2.3 million trial of a personalised twelve-week programme (medication, physiotherapy, psychological support) for women whose pain remains poorly relieved. Recruitment has not started and no results are known yet.

Read the source article

What the announcement says

The University of Aberdeen and NHS Grampian, in Scotland, are preparing a UK-wide trial devoted to endometriosis pain. It is funded to the tune of 2.3 million pounds sterling by the Health Technology Assessment programme of the UK's National Institute for Health and Care Research, the NIHR, and is to last five years (BBC, 2026). According to the BBC, preparatory work has begun, but participants have not yet been recruited.

The programme being tested is called e-PMP, for endometriosis-specific pain management programme. It lasts twelve weeks and is meant to be personalised. It combines cognitive behavioural psychotherapy, specialised physiotherapy, advice on relationships, intimacy and communication, as well as a medication component aimed at limiting the side effects of treatments (BBC, 2026).

The study is led by the gynaecologist Lucky Saraswat, head of the Aberdeen endometriosis centre. It is aimed at women who have not reached menopause and whose pain remains poorly controlled despite surgery or medication. Their specialist will offer them the chance to take part (BBC, 2026).

How the trial is built

Participants will be divided into two groups. Some will follow the programme in addition to usual care, others will receive usual care alone, and the results of the two groups will be compared (BBC, 2026). This is the principle of a controlled trial: only this comparison makes it possible to know whether an improvement comes from the programme or from something else.

The study will seek to find out whether this tailored plan improves quality of life in the long term. It will also assess its cost-effectiveness, that is, whether the gain justifies the expense for the health system (BBC, 2026). The BBC does not give details here of the number of participants expected or the exact criteria for judging results, so these points are not known at this stage.

The report opens with the testimony of Charlotte McCann, 27, who lives with stage 4 endometriosis, had to leave her job in finance and says she has not been lastingly relieved, either by surgery or by powerful painkillers that make her ill (BBC, 2026). This testimony is not trial data.

How to read this announcement

The essential point is that there are no results. A trial that has not recruited proves nothing. The remarks quoted in the article are expectations from research leaders and a charity, not findings. The researcher herself speaks in the conditional: if the programme is effective, it could become a treatment option, notably for women who wish to avoid repeated operations or hormonal treatments, or who are planning a pregnancy (BBC, 2026). The head of the funding programme speaks of a trial that could transform care: these are words of hope.

Second limit, the duration. With a five-year project, results are not to be expected for several years, and any rollout in health services would come after that. Third limit, the scope. The trial concerns women whose pain persists despite care, not everyone with the condition, and it takes place in the United Kingdom, where the organisation of care differs from that of other countries.

Finally, we must distinguish what the trial tests. It does not replace existing treatments, since the programme is added to usual care. It does not cure the disease, which remains chronic. It seeks to find out whether coordinated support for the pain, its psychological consequences and intimate life brings a measurable benefit on top.

Why this lead deserves attention

It starts from a finding that the head of the study puts this way: endometriosis is one of the most common causes of chronic pain and yet one of the least studied, and many women still suffer after an operation or a treatment (BBC, 2026). For the chair of the charity Endometriosis UK, chronic pelvic pain weighs on physical and mental health, and research on how to manage it is essential (BBC, 2026).

The interest also lies in the place given to relationships and intimacy. The programme includes advice on relationships, intimacy and communication (BBC, 2026), which acknowledges that pain does not stop at the body and affects the couple, work and morale.

What this changes for the reader

For now, nothing concrete: the programme is not available, and it will be so only to trial participants, on the recommendation of their specialist. You should therefore not wait for this programme before seeing someone. If you have period pain that prevents you from living normally, deep pain during sex or lasting pelvic pain, a health professional remains the right person to see, and it is for neither this article nor this trial to decide on a treatment in your place.

This announcement does show, however, that research is taking more interest in life with pain and not only in lesions. If its results are favourable, they could support the idea that care combining doctor, physiotherapist and psychological support has its place in endometriosis. We will have to wait to find out.

What our main page adds

Our main page recalls that the disease affects about one woman in ten of childbearing age and that it is chronic: it can be managed well in most cases, but not cured in the strict sense. Diagnosis comes on average after four to twelve years, and can now be made without surgery, thanks to transvaginal ultrasound and pelvic MRI. Against pain, it describes anti-inflammatory drugs taken from the start of the period, chronic pain management, pelvic physiotherapy and hormonal treatments that put the lesions to rest. It also addresses sexuality and the couple, and says when to see someone. The details are in our page on endometriosis.

Going further

This news item is part of a broader topic, which our page Endometriosis: pain, fertility and intimate life covers in detail.

Read the page: Endometriosis: pain, fertility and intimate life

← All news

Page checked in .

Text prepared with artificial intelligence, reviewed by the AffectionPlus team (method: About). Spotted an error? Write to us.

Locate this page in the site map